AHA Coding Clinic® for HCPCS - 2016 Issue 1; For Your Information

New HCPCS codes for certain drugs, biologicals, and radiopharmaceuticals

Several new HCPCS codes were created for the reporting of drugs and biologicals under the hospital outpatient prospective payment system (OPPS). These new HCPCS codes are listed in the table below: New HCPCS CodesHCPCS Long DescriptorC9458 Florbetaben F18, diagnostic, per study dose, up to 8.1 millicuries C9459 Flutemetamol F18, diagnostic, per study dose, up to 5 millicuries C9460 Injection, cangrelor, 1 mg Q9980 Hyaluronan or derivative, GenVisc 850, for intra-articular injection, 1 mg J0714 Injection, ceftazidime and avibactam, 0.5g/0.125g J1575 Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin J7188 Injection, factor viii (antihemophilic factor, recombinant), (obizur), per...

To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.


The AHA Coding Clinic for HCPCS includes:

  • The official publication for Level I HCPCS (CPT-4 codes) for hospital providers
  • Also specific Level II HCPCS codes for hospitals, physicians and other health professionals
  • Current newsletters added each quarter
  • Full Archives back to 2001
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information page link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - HCPCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.